SNTISenti Biosciences, Inc.

Nasdaq sentibio.com


$ 0.37 $ 0.00 (-0.3 %)    

Friday, 10-May-2024 15:54:29 EDT
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 0.3689
$ 0.37
$ 0.00 x 0
$ 0.00 x 0
$ 0.37 - $ 0.37
$ 0.27 - $ 1.10
63,346
na
16.86M
$ 2.06
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 03-21-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
4 08-11-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-22-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-16-2022 03-31-2022 10-Q
10 03-07-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-06-2021 06-30-2021 10-Q
13 07-02-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 senti-biosciences-q1-eps-026-up-from-042-yoy

Senti Biosciences (NASDAQ:SNTI) reported quarterly losses of $(0.26) per share. This is a 38.1 percent increase over losses of ...

 senti-biosciences-q4-2023-gaap-eps-042-misses-028-estimate

Senti Biosciences (NASDAQ:SNTI) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $...

 senti-biosciences--said-reducing-its-workforce-by-37-as-part-of-prioritizing-its-investment-in-lead-clinical-program

Senti Biosciences, Inc. (NASDAQ:SNTI) (“Senti Bio” or the “Company”), a clinical stage biotechnology company developing next-ge...

 why-is-blood-cancer-focused-senti-biosciences-stock-trading-higher-today

Senti Biosciences Inc (NASDAQ: SNTI) received FDA clearance for its Investigational New Drug (IND) application for SENTI-202, a...

 crude-oil-falls-sharply-datadog-shares-spike-higher

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 1% on Tuesday The Dow traded up ...

 why-sanmina-shares-are-trading-lower-by-around-15-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spe...

 nasdaq-jumps-100-points-us-trade-deficit-widens-in-september

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Tuesday The Dow tr...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION